Betmiga 25mg tablet is an antimuscarinic agent that contains an active ingredient called Mirabegron. This medicine reduces the activity and symptoms associated with an overactive bladder, such as urgency incontinence (inability to control bladder emptying), sudden urination urges, and increased urinary frequency. This medicine is not advised to use in children under 18 years old.
Betmiga 25mg tablet should not be taken if you have allergies to Mirabegron or if you have high uncontrolled blood pressure. Before starting the treatment, inform your doctor if you have trouble emptying your bladder (urinary retention) or if you are taking specific medications for HIV, fungal or bacterial infections, or anticholinergic medicine. Don't consume this medicine if you are pregnant or planning to get pregnant or breastfeeding.
Notify your doctor if you have liver or kidney problems. Your doctor may adjust your dose of Betmiga 25mg tablet in such conditions. Also, inform your doctor if you have any heart conditions, such as abnormal ECG (QT prolongation) or taking medications that may cause it.
Uses of Betmiga 25mg Tablet 30's
Therapeutic Effects of Betmiga 25mg Tablet 30's
Betmiga 25mg tablet works by stimulating beta-3 adrenergic receptors in the bladder, leading to the relaxation of the bladder muscles. This helps to increase bladder capacity and reduce urinary urgency and frequency.
Interaction of Betmiga 25mg Tablet 30's with other drugs
Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications, such as itraconazole, ketoconazole, and clarithromycin, may interact with Betmiga 25mg tablet and can cause undesirable side effects.
More Information about Betmiga 25mg Tablet 30's
How to consume Betmiga 25mg Tablet 30's
Take the Betmiga 25mg tablet as your physician advises. Do not crush, chew, or open the medicine. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the tablet if your doctor advises you to stop.
Safety Advices for Betmiga 25mg Tablet 30's
Pregnancy
Betmiga 25mg tablet is unsafe during pregnancy as it may harm the developing baby. Before starting the treatment, inform your doctor if you are pregnant or planning to get pregnant.
Breast Feeding
It is unsafe to use Betmiga 25mg tablet during breastfeeding because the medicine may pass into breast milk. Consult your doctor for advice. Inform your doctor if you are breastfeeding.
Lungs
It is unknown whether Betmiga 25mg tablet is safe for patients with lung problems. Notify your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.
Liver
Betmiga 25mg tablet is used with caution in patients with liver impairment. Inform your physician about the pre-existing live conditions. Your physician will monitor your liver functions and adjust the dose accordingly.
Alcohol
It is not known whether it is safe to drink alcohol while taking Betmiga 25mg tablet. Check with your doctor for advice.
Driving
It is unknown whether this medicine affects your ability to drive or use machines.
Side Effects of Betmiga 25mg Tablet 30's
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious
- Irregular heartbeat
- Sudden or throbbing headache
- Angioedema ( swelling of the face, mouth, or throat)
- Elevated blood pressure
Common
- Increased heart rate
- Nausea
- Constipation
- Diarrhea
- Dizziness
- Urinary tract infection
Word of Advice
Liver, heart, and kidney patients should take Betmiga 25mg tablet cautiously and inform the doctor about all the underlying medical conditions and medications you consume. Do not stop the medicine until your doctor advises. Do not double-dose the medicine to make up for a forgotten dose. Notify your doctor if you experience any serious side effects. Your medical professional will inform you if you need any dose adjustments. Contact your doctor for more information.
FAQs
Q 1. Is Betmiga 25mg tablet an anticholinergic?
No! Betmiga 25mg tablet is not an anticholinergic medication. It is a beta-3 adrenergic agonist that relaxes the bladder muscles to improve urinary symptoms. Consult your healthcare provider for more information on medication classifications.
Q 2. What is the best time of day to take the Betmiga 25mg tablet?
The best time of day to take the Betmiga 25mg tablet can vary depending on the individual and healthcare provider's recommendation. It is generally recommended to follow the prescribed dosage instructions and take medicine at the same time each day for consistency.
Q 3. What are the side effects of the Betmiga 25mg tablet?
Common side effects of Betmiga 25mg tablet include increased blood pressure, headache, dizziness, urinary tract infection, and constipation. Contact your doctor if you experience any side effects, and consult your healthcare provider for more information
Q 4. How to manage the side effects of Betmiga 25mg tablet?
To manage the side effects of the Betmiga 25mg tablet, follow your doctor's instructions, stay hydrated, and monitor blood pressure and any changes. Report severe side effects to your doctor and inform them about other medications or conditions. Maintain a healthy lifestyle and consult your doctor for personalized guidance.
Q 5. Can you take Betmiga 25mg tablet when pregnant?
It is unsafe to consume this medicine while pregnant. Consult your medical professional regarding the use of Betmiga 25mg tablet during pregnancy. The potential benefits and risks should be carefully assessed. Your doctor will suggest taking this medicine only if it's necessary
Q 6. What should I do if I miss a dose of Betmiga 25mg tablet?
If you miss a capsule dose, take it as soon as possible. However, if it's close to the time for your next dose, skip the missed dose and continue with your regular schedule. Do not double the dose of Betmiga 25mg tablet.
Fact Box of Betmiga 25mg Tablet 30's
Molecule Name: Mirabegron | Therapeutic class: Urology |
Pharmacological class: beta 3-adrenoceptor agonist
| Indications: 1. Treatment of overactive bladder (OAB) symptoms. 2. Helps control uncontrollable bladder emptying (urgency incontinence). 3. Reduces sudden urges to urinate. 4. Reduces frequent urination. |